Skip to content

Dr. Tomas Hricko

Dr. Tomas Hricko is a member of the Board of Directors of Peak Compliance AG. A mathematician with a doctorate, he focuses on quantitative risk management – liquidity risk, scenario analysis, value at risk and the structuring of structured products.

Board Member, Peak Compliance AG

Mathematician with a doctorate; his dissertation deals with the structuring of structured products.

  • Focus: quantitative risk management – liquidity risk, stress testing, value at risk and expected shortfall, concentration risk
  • Products: decomposition, valuation and risk analysis of structured products
  • Background: LinkedIn

Publications

  • Doctoral thesis (HEC Lausanne): structuring of structured products
  • Working paper on credit risk: Cossin, D., Hricko, T., Aunon-Nerin, D. and Huang, Z. (2002): «Exploring for the Determinants of Credit Risk in Credit Default Swap Transaction Data: Is Fixed-Income Markets' Information Sufficient to Evaluate Credit Risk?», FAME Research Paper No. 65 – SSRN

Articles by Dr. Tomas Hricko

Anlageprodukte & Risikomanagement · 7 November 2026 · DE Konzentrationsrisiken messen: Herfindahl-Index und Korrelationscluster

Herfindahl-Index, effektive Positionszahl, Emittenten-Look-through und Component VaR: Konzentrationsrisiken in Fonds und Mandaten mit Rechenbeispielen.

Read article →
Anlageprodukte & Risikomanagement · 29 September 2026 · DE Strukturierte Produkte: Zerlegung, Sensitivitäten und Barrierenrisiko

Barrier Reverse Convertible zerlegt: Anleihe plus Down-and-in-Put, Delta, Gamma, Vega, Barriere, Emittenten- und Liquiditätsrisiko mit Zahlenbeispiel.

Read article →
Anlageprodukte & Risikomanagement · 7 November 2026 · DE Stresstests und Szenarioanalyse: historisch, hypothetisch und revers

Faktorschocks, Duration und Konvexität, Korrelationsbruch und Reverse-Stresstest: Szenarioanalyse mit Formeln und Rechenbeispiel für Fonds und Mandate.

Read article →
Anlageprodukte & Risikomanagement · 7 November 2026 · DE Liquiditätsrisiko messen: Liquidationsdauer und Rücknahme-Stresstests

Days-to-liquidate, Liquiditätsstufen, Liquiditätsdeckung und Notverkaufsabschlag: Formeln und Rechenbeispiel zum Liquiditätsrisiko nach Art. 108a KKV.

Read article →
Anlageprodukte & Risikomanagement · 19 May 2026 · DE Value at Risk und Expected Shortfall: Berechnung, Backtesting, Limiten

VaR parametrisch, historisch und per Monte Carlo, Expected Shortfall, Kupiec-Test und die Vorgaben der KKV-FINMA für Effektenfonds mit Rechenbeispielen.

Read article →

More about the team on About us. For risk management in your institution: risk management outsourcing and get in touch.

Frequently asked questions

What is Dr. Tomas Hricko’s role at Peak Compliance?

Dr. Tomas Hricko is a member of the Board of Directors of Peak Compliance AG.

Which topics does Dr. Tomas Hricko write about?

He writes on quantitative risk management: liquidity risk, stress testing and scenario analysis, value at risk and expected shortfall, structured products and concentration risk. His articles are listed on this page.

Where can I find his professional background?

His background is on his LinkedIn profile, linked on this page. To arrange a conversation, please use the Peak Compliance contact page.

Dr. Tomas Hricko, Board Member at Peak Compliance
Responsible
Board Member · LinkedIn profile

Let us talk about your compliance

Phone, form or meeting – arrange a conversation now.